Literature DB >> 22108635

Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.

Jing Jiang1, Li-Jun Zhao, Chao Zhao, Guo Zhang, Yun Zhao, Jing-Ran Li, Xiao-Ping Li, Li-Hui Wei.   

Abstract

OBJECTIVE: The human papillomavirus (HPV) oncoprotein, E6, activates telomerase reverse transcriptase (TERT) expression and causes cellular immortalization. It remains unclear whether E6 affects TERT transcription by altering DNA methylation profiles. In this study, we explored the methylation status of the TERT promoter in cervical cancer cell lines and its variations after E6 was silenced by RNAi.
METHODS: Three kinds of cervical cell lines (HPV16 positive: CaSki and SiHa; HPV18 positive: HeLa), were taken to analyze the methylation status of the TERT promoter by methylation-specific polymerase chain reaction (MSP) and bisulfite sequencing (BS). Stealth RNAi was transiently transfected to these cell lines to silence the expression of HPV16/18 E6, and the subsequent changes of TERT mRNA levels and TERT promoter DNA methylation were examined.
RESULTS: Hypomethylation of the DNA around the TERT transcription start site (-156 to +162 bp) was functionally related to its transcription. After transfection with Stealth RNAi, the levels of HPV16/18 E6 and TERT mRNA were greatly decreased. The methylated CpG around the transcription start sites in CaSki and SiHa cells were statistically increased (respectively P=0.016, P=0.000). However, there was no significant difference in HeLa cells (P=0.128).
CONCLUSION: Hypomethylated CpG around the transcription start site enables the expression of TERT in cervical cancer cells. Our results show for the first time that HPV16 E6 can promote TERT transcription through demethylating the DNA sequence around the TERT transcription start site in cervical squamous cancer cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108635     DOI: 10.1016/j.ygyno.2011.11.023

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  16 in total

Review 1.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

2.  Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.

Authors:  Denise M Schütze; Jan M Kooter; Saskia M Wilting; Chris J L M Meijer; Wim Quint; Peter J F Snijders; Renske D M Steenbergen
Journal:  Epigenetics       Date:  2015-01-23       Impact factor: 4.528

Review 3.  Infection, mutation, and cancer evolution.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  J Mol Med (Berl)       Date:  2012-04-04       Impact factor: 4.599

4.  Association Between Type-specific HPV Infections and hTERT DNA Methylation in Patients with Invasive Cervical Cancer.

Authors:  Mónica Molano; Pablo Moreno-Acosta; Nicolás Morales; Marcela Burgos; Lina Buitrago; Oscar Gamboa; Rayner Alvarez; Suzanne M Garland; Sepehr N Tabrizi; Renske D M Steenbergen; Juan Carlos Mejía
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

5.  The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

6.  Evaluation of TERT mRNA expression using RNAscope®: A potential histopathologic diagnostic and prognostic tool.

Authors:  Amir Momeni-Boroujeni; Elham Yousefi; Sounak Gupta; Ryma Benayed; Michael F Berger; Marc Ladanyi; Robert Monroe; Jeff Kim; Achim Jungbluth; Britta Weigelt; Kay J Park
Journal:  Pathol Res Pract       Date:  2022-04-16       Impact factor: 3.309

7.  Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.

Authors:  Daniel Weiss; Christian Stockmann; Katrin Schrödter; Claudia Rudack
Journal:  Cell Oncol (Dordr)       Date:  2013-03-26       Impact factor: 6.730

8.  hTERT Protein Expression in Cytoplasm and Nucleus and its Association With HPV Infection in Patients With Cervical Cancer.

Authors:  Pablo Moreno-Acosta; MÓnica Molano; Nicolas Morales; Jinneth Acosta; Cristian GonzÁlez-Prieto; Diana Mayorga; Lina Buitrago; Oscar Gamboa; Juan Carlos MejÍa; July Castro; Alfredo Romero-Rojas; Sophie Espenel; Gerald L Murray; Suzanne M Garland; Alexis Vallard; Nicolas MagnÉ
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

9.  Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.

Authors:  Anne-Lise Peille; Veronique Brouste; Audrey Kauffmann; Pauline Lagarde; Valerie Le Morvan; Jean-Michel Coindre; Frederic Chibon; Laurence Bresson-Bepoldin
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

10.  Telomerase activity in cervical scrapes of women with high-grade cervical disease: A nested case-control study.

Authors:  Mónica Molano; Diana Carolina Martín; Pablo Moreno-Acosta; Gustavo Hernández; Alyssa Cornall; Oscar Buitrago; Oscar Gamboa; Suzanne Garland; Sepehr Tabrizi; Nubia Muñoz
Journal:  Oncol Lett       Date:  2017-11-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.